Navigation Links
Dyadic International Reports Third Quarter 2013 Financial Results
Date:11/14/2013

$

(391,594)Net Income (Loss) per Common ShareBasic

$

0.00

$

0.09

$

(0.05)

$

(0.01)Diluted

$

0.00

$

0.08

$

(0.05)

$

(0.01)Weighted Average Common Shares Used in CalculatingNet Income (Loss) Per Share:Basic32,507,98031,708,06333,240,74531,651,657Diluted34,019,67033,937,59833,240,74531,651,657 DYADIC INTERNATIONAL, INC. AND SUBSIDIARIESCONDENSED CONSOLIDATED BALANCE SHEETSSeptember 30,
2013December 31,
2012ASSETS(unaudited)Current Assets:Cash and Cash Equivalents$

8,496,333$

3,990,062Restricted Cash196,796192,355Accounts Receivable, Net1,888,3801,260,798License Fee Receivable791,2503,500,000Inventory, Net1,678,8612,765,187Prepaid Expenses and Other Current Assets183,465237,389Total Current Assets13,235,08511,945,791Fixed Assets, Net396,442393,860Intangible Assets, Net555,056525,224Other Assets128,91316,173$

14,315,496$

12,881,048LIABILITIES AND STOCKHOLDERS' EQUITYCurrent Liabilities:Accounts Payable$

1,779,946$

1,687,177Accrued Expenses785,613412,483Accrued Interest Payable171,7611,905Note Payable to Stockholder-1,424,941Deferred Research and Development Obligation314,788567,400Income Taxes Payable38,000-Total Current Liabilities3,090,1084,093,906Note Payable to Stockholder1,424,941-Convertible Subordinated Debt6,818,0007,000,00011,333,04911,093,906COMMITMENTS AND CONTINGENCIESStockholders' Equity:Preferred Stock, $.0001 Par Value:Authorized Shares – 5,000,000; None Issued and Outstanding--Common Stock, $.001 par value,Authorized Shares – 100,000,000; Issued and Outstanding R
33,240,745 and 31,656,245, Respectively33,24031,656Additional Paid-in Capital80,829,16379,847,761Stock to be Issued91,672-Accumulated Deficit(77,971,628)(78,092,275)2,982,4471,787,142$

14,315,496$

12,881,048 DYADIC INTERNATIONAL, INC. AND
'/>"/>

SOURCE Dyadic International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Dyadic International Partners with Leading Provider of Nutritional Ingredient Solutions for Production of Food Enzymes
2. Dyadic International Launches FibreZyme® G5000 High Performance Powder Pulp and Paper Enzyme in Booth #1065 at Tissue World Americas Conference
3. Dyadic International To Release First Quarter 2012 Financial Results And Host Conference Call
4. Dyadic Demonstrates Industry-leading Biofuels Enzyme Performance
5. Dyadic International to Announce Second Quarter 2012 Financial Results and Host Conference Call on Monday, August 13, 2012
6. Dyadic Netherlands To Develop Baking Enzymes For EU-Funded Research Project
7. Dyadic International Reports 2012 Third Quarter Financial Results
8. 12th U.S. Patent Issued To Dyadic International
9. Dyadic International Upgraded By OTC Markets To "Current Information" Tier
10. Dyadic International To Announce Year-End 2012 Financial Results And Host Conference Call On Thursday, March 7, 2013
11. Dyadic International To Present At World Biofuels Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... 2015  Ceres, Inc. (Nasdaq: CERE ), an ... for a genetic sequence derived from soybean, covering uses ... development and plant transformation. The company believes that its ... are the target of a class of commercial herbicides. ... license to the innovation, including an opportunity for exclusivity ...
(Date:5/26/2015)... OTTAWA, Canada, and BELLINGHAM, Washington, USA (PRWEB) May 26, ... has signed a formal partnership with the ... Ottawa Centre for Extreme and Quantum Photonics. The center ... in the field of photonics, and will be only ... Arthurs, CEO of SPIE, the international society for ...
(Date:5/26/2015)... and HILDEN, Germany ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime ... its QIAGEN Clinical Insight ® (QCI™) bioinformatics ... to interpret and report on genomic variants identified ... applications for the bioinformatics platform are in oncology, ...
(Date:5/26/2015)... Global Stem Cells Group and ... company’s first cellular and regenerative medicine symposium in Barcelona ... hands-on stem cell training class Oct. 10. The event ... President of Therapeutic Confrontations (CONFTERA) in Barcelona. , ... regenerative medicine and recent advances in cellular therapies, Global ...
Breaking Biology Technology:Ceres Awarded Patent for Innovation in Soybean 2Ceres Awarded Patent for Innovation in Soybean 3Third Max Planck Centre in North America Inaugurated at University of Ottawa 2Third Max Planck Centre in North America Inaugurated at University of Ottawa 3QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 2QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 3QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 4QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 5Stem Cell Training, Inc. Announces First European Symposium on Cellular and Regenerative Medicine 2Stem Cell Training, Inc. Announces First European Symposium on Cellular and Regenerative Medicine 3
... use, reliability and ... convenience, ... availability of easypod(R), the first of its kind,automated device in the ... [somatropin (rDNA origin) for,injection], the company,s treatment for growth hormone deficiency. ...
... proteins in their natural environment and interactions inside ... advanced microscopy technique called cryo-electron tomography, researchers from ... proteins responsible for cell-cell contacts for the first ... publish the first 3D image of human skin ...
... (NYSE: SGP ) was honored by Scrip ... industry awards: Large Pharma Company,of the Year, Management ... Year for,Fred Hassan, Schering-Plough chairman and CEO., ... and achievement,within the pharmaceutical and biotech industries. Scrip ...
Cached Biology Technology:Video and Photo: EMD Serono Launches easypod(R), New Electronic Growth Hormone Injection Device 2Video and Photo: EMD Serono Launches easypod(R), New Electronic Growth Hormone Injection Device 3Video and Photo: EMD Serono Launches easypod(R), New Electronic Growth Hormone Injection Device 4The closest look ever at native human tissue 2Schering-Plough Wins Three of Scrip's Top Pharma Industry Awards 2
(Date:5/11/2015)... RYE, N.Y. , May 11, 2015 ... company, announced the start of a new Phase III ... effect of its novel formulation, CM-AT, on all children ... results of its FDA Phase III double blinded clinical ... who had low levels of the digestive enzyme chymotrypsin. ...
(Date:5/6/2015)... TEL AVIV, Israel , May 6, 2015 /PRNewswire/ ... the world,s most established helmet producer, announced today that ... LifeBEAM Smart Helmet, the world,s first bio-sensing cycling helmet ... will be released in two new colors in order ... demand for the product. In addition, LifeBEAM and Lazer ...
(Date:4/27/2015)... FORT LAUDERDALE, Fla. , Apr. 27, 2015 /PRNewswire/ ... provider of access control and security systems is pleased ... joined the company as a consultant and member of ... Bedore is widely known as a thought leader ... Socrates Distance Learning Technology Group, and has published studies ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4
... by scientists at McGill University and the University of Zurich ... their ability to signal information. The research may explain why ... a specially formulated diet. The findings, published Jan. 16 ... processes that inhibit brain activity, such as that involved in ...
... This news release is available in French ... 2014 When it comes to global warming, there are seven ... the United Kingdom. A new study published in Environmental Research ... than 60 per cent of pre-2005 global warming. Uniquely, it also ...
... 15, 2014 MedNet Solutions , a global life ... pleased to announce that the latest version of ... iMedNet user community.  iMedNet EDC provides an ... to Sponsors and CROs wanting to quickly and easily build ...
Cached Biology News:How metabolism and brain activity are linked 2Global warming's biggest offenders 2MedNet Solutions Announces Latest Release Of Its Innovative iMedNet EDC eClinical Solution 2
Human VEGF R3/Flt-4 Phycoerythrin MAb (Clone 54733)...
Immunogen: Synthetic Peptide: V(22) N G H E F E I E G E G E G R(36) Storage: -20 C, Avoid Freeze/Thaw Cycles...
Human beta IG-H3 MAb (Clone 348506) Keywords: BIGH3, betaIG-H3 Protein Family: Extracellular Matrix Molecules...
Human Siglec-9 Biotinylated Affinity Purified Pab...
Biology Products: